Inventor · disambiguated record
David John Nash
Also filed as: NASH DAVID J · NASH DAVID JOHN
14 granted patents·14 pending applications·48 citations·filing 1993–2024
89Inventor score
Files withSMITHKLINE BEECHAM PLC7GLAXO GROUP LTD6SMITHKLINE BEECHAM LTD4AHMAD NADIA MAMOONA2ASTEX THERAPEUTICS LTD2
Top patents by PatentIndex Score
28 records- 0184US12077526B2Isoindolinone inhibitors of the MDM2-P53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2023·Granted Sep 3, 2024·1 cites·22 claims
- 0279US7166608B2N-aroyl piperazine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Jan 23, 2007·10 cites·3 claims
- 0374US7365077B2Piperazine bis-amide derivatives and their use as antagonists of the orexin receptorSMITHKLINE BEECHAM PLC·Filed 2002·Granted Apr 29, 2008·8 cites·22 claims
- 0473US7893090B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Feb 22, 2011·1 cites·11 claims
- 0571US7470710B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Dec 30, 2008·4 cites·17 claims
- 0670US2025074900A1Isoindolinone inhibitors of the mdm2-p53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0763US7928125B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Apr 19, 2011·0 cites·8 claims
- 0863US7928124B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Apr 19, 2011·0 cites·6 claims
- 0963US7897618B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Mar 1, 2011·0 cites·7 claims
- 1060US6143762ATetrahydroisoquinoline derivatives and their pharmaceutical useSMITHKLINE BEECHAM PLC·Filed 1997·Granted Nov 7, 2000·8 cites·10 claims
- 1155US7405217B2N-aroyl piperazine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2006·Granted Jul 29, 2008·0 cites·14 claims
- 1254US6274593B1Substituted tetrahydro isoquinolines as modulators of dopamine D3 receptorsSMITHKLINE BEECHAM PLC·Filed 1998·Granted Aug 14, 2001·12 cites·11 claims
- 1352US5523299A5-(2-oxyphenyl)-pyrrole derivatives as dopamine D3 receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 1993·Granted Jun 4, 1996·4 cites·13 claims
- 1446US10011767B2Green production of highly fluorescent carbon quantum dots from carbon dioxideBLAIR RICHARD·Filed 2016·Granted Jul 3, 2018·0 cites·11 claims
- 1546US2010105713A1GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric DisordersGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1645US2009325993A1GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric DisordersAHMAD NADIA MAMOONA·Filed 2008·Application pending·0 cites
- 1745US2012004273A1Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disordersAHMAD NADIA MAMOONA·Filed 2008·Application pending·0 cites
- 1844US2006040937A1N-aroyl cyclic amines as orexin receptor antagonistsGLAXO GROUP LTD·Filed 2003·Application pending·0 cites
- 1943US2010029700A11-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro [4.5]dec-3-en-2-one derivatives and their use as glycine transporter inhibitorsBRANCH CLIVE LESLIE·Filed 2007·Application pending·0 cites
- 2043US2009326027A1N-Phenyl-2-0X0-1,4-Diazaspiro [4.5] Dec-3-EN-1-YL Acetamide Derivatives And Their Use As Glycine Transporter InhibitorsCOULTON STEVEN·Filed 2007·Application pending·0 cites
- 2143US2009062360A1Compounds Which Inhibit the Glycine Transporter and Uses ThereofCOULTON STEVEN·Filed 2007·Application pending·0 cites
- 2241US2009318447A1N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1--4-piperidinyl) methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophreniaNASH DAVID JOHN·Filed 2005·Application pending·0 cites
- 2341US2009221577A1Compounds having morpholinyl and piperidinyl groups for use as glyt1 inhibitorsGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 2440US2008255144A1Acylated Piperidines as Glycine Transporter InhibitorsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 2540US2009270510A1Glycine transport inhibitorsGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 2639US2009253700A1N-'4-4(4-morpholinyl) phenyl!- '(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitorsBRANCH CLIVE LESLIE·Filed 2005·Application pending·0 cites
- 2739US2008090822A1Piperazine Derivatives As Glyt 1 InhibitorsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 2832US8785628B2Triazine derivatives as kinase inhibitorsALLEN DANIEL REES·Filed 2010·Granted Jul 22, 2014·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →